A breakdown of liraglutide cost covering the April 2026 list price, manufacturer savings cards, insurance and prior-authorization realities, the 2024 to 2025 compounding shift, and what typical out-of-pocket scenarios look like across coverage situations ranging from cash-pay to fully insured.

Online GLP-1 price quotes vary wildly because the sticker figure is only the starting point. This guide explains list price, insurance and prior authorization, savings-card exclusions, the 2024 to 2025 compounding shift, and the realistic out-of-pocket scenarios that patients actually encounter at the counter.

A "cheap GLP-1" depends far less on list price than on coverage, savings-card eligibility, pharmacy choice, and compounded pathways. This guide breaks down what genuinely lowers monthly cost as of April 2026 and where genetic context fits before you spend.

Because Zepbound is branded for weight management, coverage is often the deciding factor in what you pay. This guide covers its roughly $1,059 April 2026 list price, why the weight indication complicates insurance, and the realistic spread of monthly costs.

Tirzepatide is the single molecule behind two branded medications, yet the question people ask is always about price. This guide covers its roughly $1,069 April 2026 list price, how coverage tracks the indication rather than the molecule, and realistic out-of-pocket outcomes.

Zepbound cost depends far more on insurance, indication, and savings programs than on the drug itself. This guide breaks down list price, prior authorization, manufacturer savings cards, and compounded alternatives as of April 2026, then adds the genetic context most cost pages leave out.

Tirzepatide is the molecule inside multiple brand products, so its cost depends on the branded form, insurance, and pharmacy. This guide breaks down the April 2026 list price, coverage and savings factors, out-of-pocket scenarios, and the genetic context that informs any protocol decision.

Zepbound cost depends on more than a single number. This overview covers the published April 2026 list price, how insurance and prior authorization change the math, manufacturer and pharmacy savings, compounded alternatives, and the genetic pathway context behind these metabolic decisions.

The number to separate is Zepbound's roughly $1,059 monthly list price versus what you actually pay after everything else runs its course. This overview walks the staircase between them, insurance, indication, savings cards, and compounded pathways, and adds the genetic context PlexusDx places upstream of any protocol decision.

Every Wegovy price you see quoted online reflects a different set of variables. This guide breaks down the five factors behind the number, how coverage and Medicare decide what you pay, what compounding changed across 2024 and 2025, and three realistic out-of-pocket scenarios.

How much Wegovy costs depends entirely on your situation. This scenario-first guide starts from the published list price, then walks through what covered, partially-covered, and uninsured patients each tend to face, plus the separately priced compounded pathway, all as of April 2026.

The real cost of tirzepatide is the gap between its list price and what you pay after coverage. This guide traces the drivers, prior-authorization mechanics, savings-card caps, and compounded pathways, then explains the genetic context that should frame any protocol decision before you spend.

The price of Ozempic depends on a handful of moving parts rather than a single figure. This page identifies the drivers, from list price and insurance to savings cards and compounded options, and shows how they combine into the numbers people see quoted online.

This price guide organizes the moving parts behind Ozempic cost: the published list price, the coverage variables that reshape it, manufacturer and third-party savings, and the compounded pathway. It closes with the genetic context that sits upstream of any spending decision.

Mounjaro's 2026 price is assembled from list price, coverage, savings cards, and compounded alternatives, which is why quoted figures vary so widely. This breakdown snapshots each input around the roughly $1,069 list price, so you can read any quoted number and tell which situation it actually describes.

A scenario-based walkthrough of Mounjaro cost: the published list price, followed by three realistic out-of-pocket situations, how coverage and savings cards reshape each one, how to find your own lane, and where compounded options fit, all reported as published for April 2026.

Building a realistic GLP-1 budget means reading list price, coverage rules, manufacturer cards, coupons, and compounded pricing together. This breakdown walks each factor as of April 2026 and shows where a genetic baseline fits into planning the monthly spend wisely.

A GLP-1 rarely has one price. This guide explains how list price, insurance coverage, prior authorization, manufacturer savings cards, pharmacy coupons, and compounded options each shape what you actually pay, plus the genetic context PlexusDx brings to every metabolic decision.

Tirzepatide is a molecule sold under more than one brand, and that distinction changes the cost conversation. This guide separates the ingredient from the label, then walks through list price, coverage, savings tools, and the compounded pathway that narrowed in 2025.

Since Ozempic itself is injection-only, the pill-cost question really points at oral GLP-1 pricing. This page breaks down the published list price, how insurance and savings cards move it, where compounded oral protocols sit, and the genetic context beneath the decision.

Mounjaro's real cost comes down to a handful of drivers working together. This checklist-style guide runs through list price, insurance and BMI gates, savings cards, discount coupons, and the compounded pathway, then adds the genetic context that price alone omits.

The honest 2026 trade-off on GLP-1 medications: substantial weight loss and cardiometabolic benefits balanced against GI side effects, cost, lean-mass loss risk, and long-term maintenance. Compares branded vs compounded options and where PlexusDx Weight Management Protocols fit at $129/mo to $349/mo across six protocols.

An honest read on the cons of GLP-1 therapy — GI side effects, the boxed warning, cost, weight regain on cessation, and body composition — plus where PlexusDx Weight Management Protocols ($129/mo to $349/mo, all 50 states, no membership) fit when insurance friction is itself one of the cons.

The cheapest GLP-1 without insurance online in 2026, ranked by 12-month cash-pay total. PlexusDx Microdose GLP-1 Protocol at $129/mo flat ($1,548/year) lands below Wegovy tablets, Tuyo Health, Breeze Meds, MEDVi, and Zepbound vials — with the optional Precision Peptide Genetic Test ($298) for genetics-anchored dosing.

Mounjaro cost without insurance runs $987–$1,112/month at U.S. pharmacies in April 2026. The $25 savings card requires commercial insurance, and Lilly Direct's $499 self-pay price is for Zepbound, not Mounjaro. PlexusDx Tirzepatide Injection at $289/mo (or $249/mo on the 6-month plan) is a compounded cash-pay alternative using the same active ingredient.

CareCredit can pay for GLP-1 at Walgreens, Walmart, Sam's Club, and a few telehealth providers — but promotional 0% financing doesn't apply at retail pharmacy counters, and the standard APR is 32.99%. We run the annual cost math against PlexusDx flat cash-pay protocols ($129–$309/mo) and explain why HSA/FSA almost always beats financing.

Mounjaro is FDA-approved tirzepatide for type 2 diabetes; Zepbound is the weight-loss-indicated brand. Compare branded Mounjaro online vs cash-pay compounded tirzepatide and where PlexusDx Tirzepatide Injection ($289/mo) fits.

How HSA eligibility actually works for semaglutide, what to do if your HSA card declines at checkout, and where PlexusDx Semaglutide Injection ($189/mo), Semaglutide Oral ($289/mo and up), and Microdose GLP-1 Protocol ($129/mo) fit. PlexusDx accepts HSA card payment where your administrator permits but does not directly bill HSA.

Eight month-to-month GLP-1 providers compared against PlexusDx Weight Management Protocols on real annual cost, separate membership fees, intro-price cliffs, and genetic baseline. PlexusDx Microdose at $129/mo flat, Semaglutide Injection $189, Tirzepatide Injection $289, GLP-Squared $289 — all cash-pay, no membership.

Eden advertises $99/mo semaglutide and $199/mo tirzepatide, but a required $99/mo membership makes the true all-in cost $198 and $298 (verified July 2026). We map those numbers against the PlexusDx Weight Management Protocol lineup ($129/mo to $349/mo) and walk the annualized cost math.